Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | F2 | P00734 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 4/20 | 0.47 |
| ▸ | CES1 | P23141 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 5/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | DAO | P14920 | 1/20 | 0.39 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28573797 | 0.89 | PDCD1 (0.49) | MAPTSMN1; SMN2L3MBTL1 | |
| SCHEMBL21408400 | 0.89 | ATM (0.41) | LMNAF2CES1TDP1MAPT | |
| SCHEMBL28830274 | 0.86 | TSHR (0.46) | TSHRALDH1A1HSD17B10TP53KMT2A | |
| SCHEMBL404698 | 0.85 | MAPK1 (0.38) | LMNAF2TSHRCES1MAPK1 | |
| SCHEMBL28564573 | 0.85 | CES2 (0.43) | CES1MAPK1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL28841642 | 0.83 | CES2 (0.52) | TSHRCES1KMT2ACES2MEN1 | |
| SCHEMBL778826 | 0.83 | TDP1 (0.50) | LMNACES1TDP1ALDH1A1MAPT | |
| SCHEMBL776559 | 0.81 | KMT2A (0.47) | MAPK1ALDH1A1MAPTKMT2APOLB | |
| SCHEMBL28747778 | 0.81 | POLB (0.51) | LMNATSHRALDH1A1KMT2APOLB | |
| SCHEMBL9418408 | 0.81 | CES2 (0.49) | LMNACES1MAPK1TDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240150390-A1 | NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2024-05-09 | — | — | US | claimed |
| EP-4286393-A1 | NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE | Daiichi Sankyo Company, Limited (JP) | 2023-12-06 | — | — | EP | claimed |
| CN-116867795-A | Novel method for producing antibody-immunostimulant conjugate | 第一三共株式会社 | 2023-10-10 | — | — | CN | claimed |
| WO-2022163846-A1 | NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE | 第一三共株式会社 | 2022-08-04 | — | — | WO | claimed |
| US-20240150390-A1 | NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2024-05-09 | — | — | US | disclosed |
| CN-113354811-B | Oxazoline polymer with side chain containing amino and/or hydroxyl, preparation method and application thereof | 华东理工大学 | 2024-05-07 | — | — | CN | disclosed |
| WO-2024024935-A1 | NOVEL METHOD FOR PRODUCING ANTIBODY-DRUG CONJUGATE HAVING ANTINEOPLASTIC EFFECT | 第一三共株式会社 | 2024-02-01 | — | — | WO | disclosed |
| EP-4286393-A1 | NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE | Daiichi Sankyo Company, Limited (JP) | 2023-12-06 | — | — | EP | disclosed |
| CN-116867795-A | Novel method for producing antibody-immunostimulant conjugate | 第一三共株式会社 | 2023-10-10 | — | — | CN | disclosed |
| WO-2022163846-A1 | NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE | 第一三共株式会社 | 2022-08-04 | — | — | WO | disclosed |
| CN-110317322-B | Particulate amine-functionalized polyaryletherketone polymers and copolymers thereof | 塞特工业公司 | 2022-06-14 | — | — | CN | disclosed |
| CN-113354811-A | Oxazoline polymer with side chain containing amino and/or hydroxyl, preparation method and application thereof | 华东理工大学 | 2021-09-07 | — | — | CN | disclosed |
| WO-2002090347-A1 | AMIDE COMPOUNDS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-11-14 | — | — | WO | disclosed |
| US-20020026052-A1 | 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors | AMERICAN HOME PRODUCTS CORPORATION (US) | 2002-02-28 | — | — | US | disclosed |
| EP-0366301-B1 | Preparation of 1,4-diazabicyclo [3.2.2]nonane | PFIZER (US) | 1994-08-31 | — | — | EP | disclosed |
| US-5026845-A | 1,4-diazabicyclo[3.2.2.]nonane and intermediates for the preparation thereof | FRIEDMANN ROBERT C (US) | 1991-06-25 | — | — | US | disclosed |
| US-5026845-A | 1,4-diazabicyclo[3.2.2.]nonane and intermediates for the preparation thereof | FRIEDMANN ROBERT C (US) | 1991-06-25 | — | — | US | disclosed |
| EP-0366301-A2 | Preparation of 1,4-diazabicyclo [3.2.2]nonane | PFIZER INC. (US) | 1990-05-02 | — | — | EP | disclosed |
| US-4895943-A | Preparation of 1,4-diazabicyclo(3.2.2)nonane | PFIZER INC. (US) | 1990-01-23 | — | — | US | disclosed |
| US-4895943-A | Preparation of 1,4-diazabicyclo(3.2.2)nonane | PFIZER INC. (US) | 1990-01-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240150390-A1 | NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE | PAICS, COASY, CDS2 | LMNA 4487/4885F2 2900/4885TSHR 2895/4885 |
| US-20020026052-A1 | 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors | PKD1, PKD2, CSNK1A1 | LMNA 520/4885F2 2334/4885TSHR 1863/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.